Takotsubo syndrome as a complication in a critically ill COVID-19 patient.
Maurizio BottiroliDaniele De CariaOriana BelliAngelo CaliniPatrizia AndreoniAntonio SiragusaAntonella MoreoEnrico AmmiratiMichele MondinoRoberto FumagalliPublished in: ESC heart failure (2020)
Coronavirus disease 2019 (COVID-19) patients with cardiac injury have an increased risk of mortality. It remains to be determined the mechanism of cardiac injury and the identification of specific conditions that affect the heart during COVID-19. We present the case of a 76-year-old woman with COVID-19 pneumonia that developed a takotsubo syndrome (TTS). Although the patient presented normal left ventricular ejection fraction and normal levels of troponin on admission, after 16 days in intensive care unit due to respiratory distress, she suddenly developed cardiogenic shock. Shock occurred few hours after a spontaneous breathing trial through her tracheostomy. Bed-side echocardiographic revealed apical ballooning promptly supporting the diagnosis of TTS. She was successfully treated with deep sedation and low dosage of epinephrine. The relevance of this case is that TTS can occur in the late phase of COVID-19. Awareness of late TTS and bed-side echocardiographic evaluation can lead to prompt identification and treatment.
Keyphrases
- coronavirus disease
- left ventricular
- ejection fraction
- aortic stenosis
- sars cov
- case report
- intensive care unit
- heart failure
- mechanical ventilation
- respiratory syndrome coronavirus
- hypertrophic cardiomyopathy
- mitral valve
- left atrial
- cardiac resynchronization therapy
- acute myocardial infarction
- pulmonary hypertension
- clinical trial
- single cell
- study protocol
- type diabetes
- bioinformatics analysis
- randomized controlled trial
- cardiovascular events
- coronary artery disease
- phase iii
- acute coronary syndrome
- cardiovascular disease
- aortic valve
- transcatheter aortic valve replacement
- smoking cessation
- respiratory tract
- open label